收藏切换
A new therapeutic agent for adult chronic idiopathic constipation, lactitol
收藏切换
Shao-qiang LI1, 2, Jian-chun LI1, Ya-tong ZHANG2, Xin HU2
Chinese Journal of New Drugs | 2021, 30(16) : 1451 - 1455
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(16): 1451-1455
A new therapeutic agent for adult chronic idiopathic constipation, lactitol
Full
Shao-qiang LI1, 2, Jian-chun LI1, Ya-tong ZHANG2, Xin HU2
Affiliations
  • 1Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science, Peking University, Beijing 100083, China
  • 2Department of Pharmacy, National Center of Geriatrics, Assessment of Clinical Drugs Risk and Individual Application Key Laboratory, Beijing Hospital, Beijing 100730, China
Published: 2021-08-30
Outline
收藏切换

Lactotol was first registered by Novartis in Switzerland in 1985. Its trade name is Importal. It is used for the treatment of hyperammonemia caused by hepatic encephalopathy. On February 12, 2020, it was approved by the US FDA for the treatment of chronic idiopathic constipation in adults. Its trade name is Pizensy. Latitol can increase the defecation frequency of patients, and the treatment efficacy for chronic idiopathic constipation in adults is not inferior to that of rubiprostone. The most common adverse reactions are upper respiratory tract infection, abdominal distension and diarrhea. The mechanism of action, pharmacokinetics, effectiveness, and safety of lactitol were reviewed in this article.

lactitol  /  adult chronic idiopathic constipation  /  clinical efficacy
李少强, 李健春, 张亚同, 胡欣. 新型成人慢性特发性便秘治疗药物乳糖醇. 中国新药杂志, 2021 , 30 (16) : 1451 -1455 .
Shao-qiang LI, Jian-chun LI, Ya-tong ZHANG, Xin HU. A new therapeutic agent for adult chronic idiopathic constipation, lactitol[J]. Chinese Journal of New Drugs, 2021 , 30 (16) : 1451 -1455 .
Year 2021 volume 30 Issue 16
51
9
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-28
  • Published:2021-08-30
Article Data
Affiliations
History
  • Accepted:2021-01-15
Affiliations
    1Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science, Peking University, Beijing 100083, China
    2Department of Pharmacy, National Center of Geriatrics, Assessment of Clinical Drugs Risk and Individual Application Key Laboratory, Beijing Hospital, Beijing 100730, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT